TICKERNERD
Menu
LFVNLFVNConsumer Defensive · Packaged Foods

LFVN Stock Forecast: LifeVantage Corp. Price Predictions for 2026-2027

Last close, 2 Oct 2026
$6.07
−2.72% on the day

The 2 Wall Street analysts covering LifeVantage Corp. hold a median 12-month price target of $7.5 — +23.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 79 of 100 as at 3 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$78.6M
Ticker Nerd rank
79 / 100
Median analyst target
$7.50
Analysts covering
2
Revenue$42.4M−23.1% y/y
Operating income$1.7M
Net income$1.3M
Free cash flow$3.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−3.0%
1M
−1.0%
YTD
+1.2%
1Y
−34.5%
From 52W high
−42.8%
From 52W low
+53.6%
$4
$11
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

LFVN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores LifeVantage Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Oct 2026
79 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
99
Quality
94
Issuance
87
Accruals
86
Volatility
79
Size
78
Revisions
31
Growth
23
Momentum
15

Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (15): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

LFVN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on LFVN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$6$8$10$12Jan 26Apr 26Jul 26Oct 26LFVNHigh $9.00Median $7.50Low $6.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
1 Buy1 Hold0 Sell
Low $6.00Median $7.50High $9.00

The green dot is the last close — the median target sits +23.6% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
28 Aug 2026Lake StreetMaintainsHold$5.00 → $6.00
7 May 2026Lake StreetDowngradeHold$5.00
7 May 2026Lake StreetDowngradeHold—
18 Feb 2026Freedom BrokerMaintainsBuy—
14 Nov 2025Freedom BrokerMaintainsBuy—
14 Jan 2025Craig-HallumInitiatesBuy—
19 Dec 2024Lake StreetInitiatesBuy—
12 Feb 2014Imperial CapitalInitiatesIn-Line—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. LFVN appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

LFVN vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, LifeVantage Corp. returned −34.5% against +16.2% for the S&P 500, dividends included.

LFVN vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Jan 26Apr 26Jul 26Oct 26LFVNS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

LFVN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−29.2%
Analysts raising
1
Analysts cutting
2
Fundamentals

LifeVantage Corp. (LFVN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
16.0×

Cheaper than 43% of US stocks

Price / sales
0.4×

Cheaper than 84% of US stocks

Price / book
2.3×

Cheaper than 39% of US stocks

EV / EBITDA
7.7×

Cheaper than 46% of US stocks

Growth & margins
Revenue growth (YoY)
−23.1%

Higher than 11% of US stocks

Earnings growth (YoY)
−34.7%

Higher than 15% of US stocks

Gross margin
78.0%

Higher than 89% of US stocks

Operating margin
3.9%

Higher than 52% of US stocks

Net margin
2.8%

Higher than 54% of US stocks

Returns & dividend
Return on equity
14.9%

Higher than 74% of US stocks

Return on assets
6.2%

Higher than 82% of US stocks

Dividend yield
3.2%

Higher than 65% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

LifeVantage Corp. (LFVN) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • LifeVantage Corp. has a market value of $78.6M and an enterprise value of $73.1M.

  • Revenue in the twelve months to 30 June 2026: $182.6M. The latest quarter shrank 23.1% year on year.

  • Net income over the same four quarters: $5.1M, a 2.8% net margin.

  • Diluted earnings per share, trailing twelve months: $0.40.

  • Free cash flow in the twelve months to 30 June 2026: $6.7M.

  • LifeVantage Corp. spent $5.7M on share buybacks and $2.3M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 12.5M.

  • Trailing P/E: 16.0×; forward P/E: 16.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 3.19%, paying out 46% of earnings.

  • LifeVantage Corp. employs 209 people — $874K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 2 Oct 2026

Data provided by Twelve Data

Peers

LFVN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods
CompanyMarket capTKN rank
LFVNLifeVantage Corp.$78.6M
79
FTLFFitLife Brands, Inc.$86.6M
39
BOFBranchOut Food, Inc.$62.8M
23
CLNNClene, Inc.$58.0M
24
BRIDBridgford Foods Corp.$50.7M
29
HAINThe Hain Celestial Group, Inc.$47.2M
58
BYNDBeyond Meat, Inc.$150.9M
35

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own LifeVantage Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest LFVN news & analysis

LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth

MarketBeat · 24 Sept 2026positive

LifeVantage executives outlined a turnaround plan during a Water Tower Research conference discussion, centered on strengthening the company's brand, improving consumer relevance, and increasing operating efficiency.

Why it matters — LFVN watchers would care because the company's leadership has publicly laid out a strategic direction focused on rebuilding the brand, improving margins, and restoring growth.

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026

GlobeNewsWire · 18 Sept 2026neutral

LifeVantage announced that CEO Terrence Moorehead and CFO Carl Aure will participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026. The announcement was made by the company on September 18, 2026.

Why it matters — Investors in LifeVantage may gain insight into the company's outlook when its top executives present at the virtual investor conference.

LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript

Seeking Alpha · 27 Aug 2026neutral

Seeking Alpha published a transcript of LifeVantage Corporation's Q4 2026 earnings call. The excerpt contains only the headline and source, with no details on the company's financial results or commentary.

Why it matters — A LifeVantage watcher would care because the earnings call transcript provides direct insight into the company's quarterly performance and management's outlook.

Lifevantage Q4 Earnings Call Highlights

MarketBeat · 27 Aug 2026negative

Lifevantage (LFVN) reported lower fourth-quarter and fiscal 2026 results, citing fewer orders, lower average order sizes, and a difficult comparison against prior-year sales of its MindBody GLP-1 System. The decline was discussed during the company's Q4 earnings call.

Why it matters — LFVN watchers would follow this because the company's recent financial results point to weakening demand, with declines in both order volume and order size, and the prior-year GLP-1 product sales creating a challenging comparison.

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

GlobeNewsWire · 27 Aug 2026neutral

LifeVantage Corporation reported its financial results for the fourth fiscal quarter and full fiscal year 2026, covering the quarter ended June 30, 2026. The results were announced via a press release from Salt Lake City on Aug. 27, 2026.

Why it matters — LifeVantage watchers would care because this announcement provides the company's official fourth-quarter and full-year financial results, which are key indicators of its recent performance.

FAQ

Frequently asked questions about LFVN stock

What is the LFVN stock price forecast for 2026-2027?

The 2 Wall Street analysts covering LifeVantage Corp. have a median 12-month price target of $7.5, with estimates ranging from $6 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is LFVN stock a buy right now?

Of the 2 analysts covering LifeVantage Corp., 1 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks LifeVantage Corp. 79 out of 100 across roughly 4,600 US stocks as at 3 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank LFVN?

As at 3 Oct 2026, LifeVantage Corp. ranks 79 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).

Will LFVN stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +23.6% from the last close, and Ticker Nerd's factor model ranks LifeVantage Corp. 79 out of 100 as at 3 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the LFVN stock forecast for 2030?

No analyst covering LifeVantage Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LFVN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $6 to $9 over the next 12 months.

How has LFVN stock performed over the past year?

LifeVantage Corp. returned -34.5% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does LifeVantage Corp. do?

LifeVantage Corporation is a health and wellness company that develops and sells nutrigenomic activators, dietary supplements, nootropics, weight management products, and skin and hair care items. Its product portfolio includes Protandim, TrueScience, PhysIQ, Axio, and Petandim, which are marketed to support cellular health, personal care, energy, and wellness routines.

What is the latest news on LFVN?

The most recent item we track (MarketBeat, 24 Sept 2026): "LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth". LifeVantage executives outlined a turnaround plan during a Water Tower Research conference discussion, centered on strengthening the company's brand, improving consumer relevance, and increasing operating efficiency.

Company

About LifeVantage Corp.

LifeVantage Corporation is a health and wellness company that develops and sells nutrigenomic activators, dietary supplements, nootropics, weight management products, and skin and hair care items. Its product portfolio includes Protandim, TrueScience, PhysIQ, Axio, and Petandim, which are marketed to support cellular health, personal care, energy, and wellness routines. The company serves customers through a direct-selling model and operates across international markets in the Americas, Asia-Pacific, and Europe. LifeVantage Corporation focuses on science-based consumer health products that combine nutrition, beauty, and wellness, giving it a distinct position in the global nutritional supplements and personal care market.

CEO Mr. Terrence O. Moorehead · 209 employees · United States · https://www.lifevantage.com